879
Participants
Start Date
December 31, 2005
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Xaliproden (SR57746A)
oral administration
Placebo
oral administration
Oxaliplatin
IV administration
5-Fluorouracil
IV administration
Leucovorin
IV administration
Sanofi-Aventis Administrative Office, Bridgewater
Sanofi-Aventis Administrative Office, Buenos Aires
Sanofi-Aventis Administrative Office, Macquarie Park
Sanofi-Aventis Administrative Office, São Paulo
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Santiago
Sanofi-Aventis Administrative Office, Berlin
Sanofi-Aventis Administrative Office, Budapest
Sanofi-Aventis Administrative Office, Milan
Sanofi-Aventis Administrative Office, Warsaw
Sanofi-Aventis Administrative Office, Porto Salvo
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Guildford Surrey
Lead Sponsor
Sanofi
INDUSTRY